ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Jianjun Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4707-378X; OpenAlex author ID A5100439784. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

First-generation high-affinity ST14 radiopharmaceutical: Design, synthesis, and preclinical PET imaging evaluation for pancreatic cancer detection. Last author DOI 10.1016/j.bioorg.2024.108085 ↗
PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer. Last author DOI 10.7150/ijms.61771 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tukang Peng · 1 shared paper, 2025 · strength 0.33
- Paper First-generation high-affinity ST14 radiopharmaceutical: Design, synthesis, and preclinical PET imaging evaluation for … DOI 10.1016/j.bioorg.2024.108085 ↗
Haitao Zhao · 1 shared paper, 2025 · strength 0.33
- Paper First-generation high-affinity ST14 radiopharmaceutical: Design, synthesis, and preclinical PET imaging evaluation for … DOI 10.1016/j.bioorg.2024.108085 ↗
Jiajin Li · 1 shared paper, 2021 · strength 0.15
- Paper PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer. DOI 10.7150/ijms.61771 ↗
Gang Huang · 1 shared paper, 2021 · strength 0.15
- Paper PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer. DOI 10.7150/ijms.61771 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.